Patents Examined by Tracy Liu
  • Patent number: 10925820
    Abstract: An oral care composition containing at least 4% fatty amphiphile and from about 0.4% to about 5%, by weight of the composition, total flavor components. The flavor components contain at least 14%, by weight of the flavor components, of one or more high displaying flavor components.
    Type: Grant
    Filed: March 31, 2017
    Date of Patent: February 23, 2021
    Assignee: The Procter & Gamble Company
    Inventors: Steven Hamilton Hoke, Sanjeev Midha, Lawrence Edward Dolan, Michael Jude Leblanc, Karen Lehnhoff, Pierig Jean-Marie Lepont, Jianjun Justin Li, Laura H. Lucas
  • Patent number: 10925997
    Abstract: A bone bioactive composition and kits comprising the composition, means for applying it and/or a metal implant are provided. The bone bioactive composition comprises a water-based salt solution comprising sodium dihydrogen phosphate and sodium chloride, and may also comprise additional elements. The composition and the kits are useful for promoting osteogenesis, particularly when a metal implant is used but also in case of periodontal diseases.
    Type: Grant
    Filed: October 26, 2017
    Date of Patent: February 23, 2021
    Assignee: BIOINTELLIGENCE SYSTEMS S.L.
    Inventors: Maher Al Atari Abouasi, José Luis Calvo Guirado
  • Patent number: 10918753
    Abstract: The present disclosure is directed to a method for reducing bacteria in a precipitated calcium carbonate (CaCO3) slurry, the method including: adding water to calcium oxide (CaO) to form Ca(OH)2; treating the Ca(OH)2 with CO2 gas to form a slurry including precipitated CaCO3; neutralizing the slurry; and exposing the slurry that was neutralized to ozone in an amount sufficient to reduce bacteria in the precipitated calcium carbonate slurry. Oral care compositions including the precipitated calcium carbonate of the disclosed process are also described.
    Type: Grant
    Filed: December 1, 2014
    Date of Patent: February 16, 2021
    Assignee: Colgate-Palmolive Company
    Inventors: Nilza Shimohirao, Mohamad Bazazan, Erico Prat
  • Patent number: 10898449
    Abstract: The present invention relates to transdermal therapeutic systems (TTS) for the transdermal administration of asenapine comprising a self-adhesive layer structure containing a therapeutically effective amount of asenapine, such asenapine TTS for use in a method of treatment, processes of manufacture of such TTS as well as asenapine and transdermal therapeutic systems containing asenapine for use in a method of treatment and to a method of treating a human patient by transdermal administration of asenapine.
    Type: Grant
    Filed: February 11, 2020
    Date of Patent: January 26, 2021
    Assignee: LTS LOHMANN THERAPIE-SYSTEME AG
    Inventors: Patrick Mohr, René Rietscher, René Eifler, Olga Bourquain
  • Patent number: 10888508
    Abstract: A multifunctional dental composition may include polyoxyethylene sorbitan monooleate; sorbitan monooleate; benzoate sodium; distilled water; and ethylene diamine tetra acetic acid. For dental use, the required hydrophilic/lipophilic balance of the composition may be 7; and a critical micellar concentration of the composition may be 0.5%. The dental composition may be applied in a manner similar to how tap water is conventionally used, and the composition may be delivered to the dental unit system using various methods.
    Type: Grant
    Filed: June 21, 2018
    Date of Patent: January 12, 2021
    Inventors: Saied Mostafa Moazzami, Hosein Orafaee
  • Patent number: 10888530
    Abstract: Provided herein are implantable compositions and methods of use thereof for the local delivery of therapeutically active agents.
    Type: Grant
    Filed: December 18, 2017
    Date of Patent: January 12, 2021
    Assignee: AcuityBio Corporation
    Inventors: John Schwartz, Aaron Henry Colby
  • Patent number: 10881745
    Abstract: A gel formulation has been developed which provides high loading, e.g., between about 5% and about 50% wt/wt agent/total gel weight, of a wide range of agents, especially amine-containing compounds such as local anesthetic agents that are known to be difficult to encapsulate, and which adhere to charged surfaces. Examples of pharmaceutically important amines include anesthetics, such as lidocaine. Tuning the ionic strength of an aqueous medium during preparation, suspension, and dialysis purification of the hydrogel composition allows for retention and/or control of agent loading contents, as well as a high capacity for adhesion to charged surfaces mimicking inflamed tissue. In some instances, the rheological properties of the gel can be tuned such as to impart thixotropic properties to the gels formed.
    Type: Grant
    Filed: May 8, 2018
    Date of Patent: January 5, 2021
    Assignee: ALIVIO THERAPEUTICS, INC.
    Inventors: Derek G. van der Poll, Dominick J. Blasioli, Gregory T. Zugates
  • Patent number: 10857097
    Abstract: There is provided a solid dosage form adapted for the release of a biologically active material in the oral cavity wherein the dosage form includes at least one biologically active material, and at least one matrix forming agent, wherein the dosage form substantially dissolves in the oral cavity. A method of producing the same and a kit including the same are also provided.
    Type: Grant
    Filed: June 27, 2018
    Date of Patent: December 8, 2020
    Assignee: iX Biopharma Ltd.
    Inventors: Chin Beng Stephen Lim, Vivian Bruce Sunderland, Yip Hang Eddy Lee
  • Patent number: 10842724
    Abstract: A composition for mixing with water for use as an oral rinse, comprising monobasic sodium phosphate, dibasic sodium phosphate, sodium chloride, and calcium chloride.
    Type: Grant
    Filed: November 2, 2018
    Date of Patent: November 24, 2020
    Assignee: Forward Science Technologies, LLC
    Inventors: Brian Pikkula, Robert J. Whitman
  • Patent number: 10835459
    Abstract: The present invention relates to a three-dimensional molding type powder makeup cosmetic composition, wherein the powder makeup cosmetic composition has a soft feeling of use and excellent adhesion and sustain power and mitigates the generation of creases by containing a powder phase in an oil gel phase and the powder makeup cosmetic composition can be molded into various three-dimensional designs due to physical characteristics of the oil gel phase.
    Type: Grant
    Filed: August 2, 2017
    Date of Patent: November 17, 2020
    Assignee: COSON CO., LTD
    Inventors: Young Ju Kim, Chan Gi Lee
  • Patent number: 10828391
    Abstract: Methods of making tissue fillers are provided. In certain embodiments, the tissue is flake-like and has regenerative properties.
    Type: Grant
    Filed: May 27, 2016
    Date of Patent: November 10, 2020
    Assignee: LifeCell Corporation
    Inventors: Wenquan Sun, Melissa Richter Bowley, Raghav Goel
  • Patent number: 10828255
    Abstract: A submicron structure comprising a silica body defining a plurality of pores that are suitable to receive molecules therein, and having a surface, and a phospholipid bilayer coating the surface, wherein said submicron structure has a maximum dimension of less than one micron, and wherein the phospholipid bilayer stably seals the plurality of pores; and wherein the submicron structure is a member of a monodisperse population of submicron structures.
    Type: Grant
    Filed: March 5, 2014
    Date of Patent: November 10, 2020
    Assignee: The Regents of the University of California
    Inventors: Andre E. Nel, Jeffrey I. Zink, Huan Meng
  • Patent number: 10813849
    Abstract: The present invention provides rechargeable dental materials that can be widely applied in a variety of dental applications. The rechargeable dental materials of the invention may be included in dental primers, dental adhesives, dental resins, dental composites, dental bonding systems and the like, as well as dental cements, dental sealants, dental bases and dental liners, each of which is rechargeable with calcium and phosphate ions. The present invention also provides for a method of recharging the rechargeable dental material with calcium and phosphate ions.
    Type: Grant
    Filed: February 5, 2016
    Date of Patent: October 27, 2020
    Assignee: UNIVERSITY OF MARYLAND, BALTIMORE
    Inventors: Huakun Xu, Michael D. Weir, Ling Zhang
  • Patent number: 10806829
    Abstract: Medical devices comprise a polymeric body comprising: a base polymeric formulation comprising at least a polymer or co-polymer of propylene; and an additive comprising a copolymer having a polypropylene backbone and hybrid micromolecule side-chains based on organo-functional silanes (PP-g-XSiOA) in the presence of a co-agent, for example, difunctional metallic diacrylate monomers, where “X” is an organic group or an organo-functional group, and “A” is a metal, an inorganic oxide, an inorganic hydroxide, or any other inorganic material. X may be derived from a compound selected from the group consisting of epoxy, amino, acrylate, methacryloxy, and vinyl; and A is selected from the group consisting of: silicon, (Si), aluminum (Al), iron (Fe), titanium (Ti), silver (Ag), zinc (Zn), nickel (Ni), calcium (Ca), copper (Cu), tin (Sn); oxides thereof; hydroxides thereof; and mixtures of the foregoing. Antimicrobial agents are included in the polymeric body. The medical devices have enhanced antimicrobial properties.
    Type: Grant
    Filed: August 17, 2018
    Date of Patent: October 20, 2020
    Assignee: Becton, Dickinson and Company
    Inventors: Theresa Hermel-Davidock, Tea Datashvili
  • Patent number: 10799612
    Abstract: Disclosed is an implanted device, comprising a device base body and an active drug, wherein the device base body is pure zinc and/or a zinc alloy, the zinc content in the device base body is 0.1-100%, and the active drug comprises anti-allergic drugs. After the implantation of the implanted device into the human body, the surrounding tissues of the implant would not have a clear hypersensitive reaction due to the presence of the anti-allergic drugs, and the implanted device can be used to be implanted into the body for supporting organ chambers, to fill the hollow chambers of the organs and tissues or as orthopaedic implants etc.
    Type: Grant
    Filed: June 27, 2016
    Date of Patent: October 13, 2020
    Assignee: Lifetech Scientific (Shenzhen) Co. Ltd.
    Inventors: Deyuan Zhang, Liping Chen, Haiping Qi, Hongtao Sun, Jun Hu, Wenjiao Lin
  • Patent number: 10792237
    Abstract: An aqueous surfactant composition comprising one or more alpha-sulfo fatty acid disalts (A) of the general formula (I), R1CH(SO3M1)COOM2??(I), wherein the radical R1 is a linear or branched alkyl or alkenyl radical with 6 to 18 carbon atoms and the radicals M1 and M2, independently of one another, are selected from the group H, Li, Na, K, Ca/2, Mg/2, ammonium, and alkanolamine, one or more amidoalkylbetaines (B) of the general formula (II), R2—CO—NH—(CH2)y—N+(CH3)2—CH2—COO???(II) in which the radical R2 is a linear or branched alkyl or alkenyl radical with 7 to 19 carbon atoms and the index y is an integer in the range 2 to 4, and water, where specific limiting conditions are to be observed. The compositions are transparent, storage-stable, characterized by good foaming ability and good viscosity, and are suitable for cosmetic products and also detergents and cleaners.
    Type: Grant
    Filed: January 23, 2015
    Date of Patent: October 6, 2020
    Assignee: BASF SE
    Inventors: Claudia Brunn, Ansgar Behler, Detlev Stanislowski, Monika Barbenheim
  • Patent number: 10765610
    Abstract: An oral care composition containing a gel phase, potassium nitrate, a peroxide source, an abrasive, and a fluoride source. Phase separation is not visually perceptible in the oral care composition.
    Type: Grant
    Filed: March 31, 2017
    Date of Patent: September 8, 2020
    Assignee: The Procter & Gamble Company
    Inventors: Sanjeev Midha, Lawrence Edward Dolan
  • Patent number: 10758461
    Abstract: An oral care composition containing a gel phase, potassium nitrate, an abrasive, and a fluoride source. The gel network phase contains a cold dispersible fatty amphiphile and phase separation is not visually perceptible in the oral care composition.
    Type: Grant
    Filed: March 31, 2017
    Date of Patent: September 1, 2020
    Assignee: The Procter & Gamble Company
    Inventors: Sanjeev Midha, Lawrence Edward Dolan
  • Patent number: 10744086
    Abstract: There is provided a fast dissolving solid dosage form adapted for the release of a biologically active material in the oral cavity wherein the dosage form comprises at least one biologically active material, and at least one matrix forming agent, wherein the dosage form substantially dissolves in the oral cavity. A method of producing the same and a kit comprising the same are also provided.
    Type: Grant
    Filed: October 26, 2010
    Date of Patent: August 18, 2020
    Assignee: iX Biopharma Ltd.
    Inventors: Chin Beng Stephen Lim, Vivian Bruce Sunderland, Yip Hang Eddy Lee
  • Patent number: 10722465
    Abstract: An aqueous, intra-oral, transparent nanoemulsion blend in the form of a stable dispersion is provided that delivers both oil- and water-soluble components of a vitamin supplement in the desired concentrations to the cells of a mammal when orally administered. The transparent nanoemulsion blend includes at least two different bilayer water-core liposome components and at least one monolayer surfactant bound particle component. The transparent nanoemulsion blend optionally may include a micelle formed from phosphatidylcholine (PC).
    Type: Grant
    Filed: December 10, 2018
    Date of Patent: July 28, 2020
    Assignee: Quicksilber Scientific, Inc.
    Inventors: Christopher W. Shade, Steven Tieu